Peptide vaccines for cancers expressing tumor-associated antigens
Номер патента: HRP20131044T1
Опубликовано: 06-12-2013
Автор(ы): Ryuji Ohsawa, Takuya Tsunoda
Принадлежит: Oncotherapy Science, Inc.
Опубликовано: 06-12-2013
Автор(ы): Ryuji Ohsawa, Takuya Tsunoda
Принадлежит: Oncotherapy Science, Inc.
Реферат: The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: 110, 111, 387, 112, 394, 114, 116, 117 or 121 as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several (e.g., up to 5) amino acids are substituted, deleted, or added, provided the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with over-expression of the HIG2, e.g. cancers containing as an active ingredient one or more of these peptides. The peptides of the present invention find further utility as vaccines.
Peptide vaccines for cancers expressing tumor-associated antigens
Номер патента: KR101543623B1. Автор: 타쿠야 츠노다,류지 오사와. Владелец: 온코세라피 사이언스 가부시키가이샤. Дата публикации: 2015-08-11.